Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-018524

Options or other derivatives

  • Director acquired 14,583 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tanguler Tolga Director 2025-06-26 Grant or award · Stock Option (right to buy) +14,583 14,583 D
Loading xslF345X05/form4-06302025_050616.xml…